ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES, S.A. - Spain 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2012 0 8.000.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
COMMISSARIAT A L'ENERGIE ATOMIQUE1
F HOFFMANNLA ROCHE1
FUNDACIO INSTITUT DE RECERCA BIOMEDICA1
MEDIZINISCHE HOCHSCHULE HANNOVER1
PARTICIPANT LEGAL NAME ISTITUTO ONCOLOGICO VENETO IRCCS1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT1
SEROSCIENCE KUTATO FEJLESZTO ES KERESKEDELMI KORLATOLT FELELOSSEGU TARSASAG1
SIGMOID PHARMA LIMITED1
UNIVERSIDAD DE SANTIAGO DE COMPOSTELA1
UNIVERSITE CATHOLIQUE DE LOUVAIN1
UNIVERSITE D'ANGERS1
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK1
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN1
UNIVERSITY COLLEGE LONDON1
UPPSALA UNIVERSITET1
VENETO NANOTECH SOCIETA CONSORTILEPER AZIONI1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2012-05-01New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier TRANS-INTparticipant8.000.00017